Immy Revenue and Competitors

The Company IMMY was founded in 1979 to produce fungal diagnostic products. IMMY then attracted a staff of knowledgable, qualified people who remain dedicated to quality and innovation. The company is located outside Norman, Oklahoma, the home of the University of Oklahoma, and the heartland of the United States. The Purpose The idea behind the founding of IMMY was that mycology was virtually a forgotten area in the clinical laboratory and diagnostic products for the mycoses would greatly benefit patients with mycotic infections. Initially, we concentrated on systemic mycoses (histoplasmosis, blastomycosis, coccidioidomycosis, and cryptococcosis). Subsequently, we have expanded the product line into the opportunistic and more esoteric fungi such as Aspergillus sp., Candida albicans, Paracoccidioides, etc. The Diseases Human and animal infections with these organisms can involve skin, lung, liver, spleen, lymph nodes, meninges, etc., and their severity can be from chronic to acute-life threatening. Infections can occur in individuals who appear to be immunologically normal, but are most common in immuno- compromised subjects (AIDS, cancer, leukemia, and diabetes). The Services IMMY has expanded into other areas such as custom products for industry and research and a CLIA licensed Mycology Reference Laboratory, Cerodex Laboratories, Inc. The custom products include affinity and chemically purified antigens and antibodies, produced to the customer's specifications. Cerodex Laboratories accepts specimens and cultures and provides testing and identification services.